Pathological and Survival Outcomes Associated with Variant Histology Bladder Cancers Managed by Cystectomy with or without Neoadjuvant Chemotherapy

PURPOSE: Although neoadjuvant chemotherapy is associated with a survival advantage in pure urothelial, muscle invasive bladder cancer, the role of neoadjuvant chemotherapy is less clear in variant histology or urothelial carcinoma with divergent differentiation. We compared chemotherapy response and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Urol
Autors principals: Hajiran, Ali, Azizi, Mounsif, Aydin, Ahmet M., Zemp, Logan, Peyton, Charles C., Dhillon, Jasreman, Nealon, Samantha, Reich, Richard R., Cao, Biwei, Li, Roger, Manley, Brandon J., Sexton, Wade J., Gilbert, Scott M.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7864376/
https://ncbi.nlm.nih.gov/pubmed/32783489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JU.0000000000001325
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars